Neuland Laboratories jumps on receiving EIR from USFDA for Hyderabad facility

08 May 2020 Evaluate

Neuland Laboratories is currently trading at Rs. 437.00, up by 19.55 points or 4.68% from its previous closing of Rs. 417.45 on the BSE.

The scrip opened at Rs. NA and has touched a high and low of Rs. 458.00 and Rs. 436.00 respectively. So far shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 734.20 on 16-May-2019 and a 52 week low of Rs. 247.30 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 458.00 and Rs. 410.70 respectively. The current market cap of the company is Rs. 535.58 crore.

The promoters holding in the company stood at 35.86%, while Institutions and Non-Institutions held 33.72% and 30.42% respectively.

Neuland Laboratories has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located at Pashamylaram, Hyderabad. The facility was inspected from February 3, 2020 to February 7, 2020. The inspection has now been closed by the USFDA.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Neuland Laboratories Share Price

13788.95 -503.80 (-3.52%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.